AAPath 2026 Continuing Medical Education (CME)
AAPath is pleased to offer Continuing Medical Education for select meeting sessions. CME is included in the meeting registration rate for physicians. Claims will be available for in-person or remote session attendance and on-demand viewing of the recorded sessions after the conference. By attending the programmed sessions and viewing the recordings of the concurrent sessions after the conference, participants will be able to maximize their credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. All other CME information and disclosures are posted below.
All submissions will be reviewed by AAPath staff prior to issuing CME certificates. Certificates will be sent to the email address provided on the CME claim submission form within 4-6 weeks of claim submissions. Certificates will be issued on a monthly basis through the week following the claim deadline. All other CME information and disclosures will be posted here when available. If you have any questions about CME credits, please contact the AAPath Office at: [email protected].
AAPath 2026 Annual Meeting CME Program
ACTIVITY DESCRIPTION: The AAPath 2026 Annual Meeting is an “other/blended” learning activity (live course and enduring material) that provides educational activities designed to provide training and professional development for academic pathologists.
TARGET AUDIENCE: The live session presentations and discussions, and recordings of most of the live sessions, provide educational activities for four target audiences:
- Chairs, Vice Chairs, and former Chairs (Senior Fellows) of academic departments of pathology and laboratory medicine;
- Program Directors and Associate Program Directors of pathology residency training programs;
- Pathology faculty educators for medical students; and
- Other faculty members and trainees (fellows, residents, and medical students) aspiring to these faculty and/or leadership positions.
The target audience include physicians/physician-scientists (MD, DO, PhD) and others who serve as the medical, scientific, and administrative leaders of academic departments of pathology and laboratory medicine in the United States and Canada.
EDUCATIONAL OBJECTIVES: The objective of the learning activity is to facilitate knowledge acquisition to enable departments to fulfill their missions in clinical service, teaching, and research. Content focuses on issues in three broad areas that address educational needs in knowledge, competency, and performance:
- ADMINISTRATION/LEADERSHIP FOR PATHOLOGY PRACTICE: Developing and refining leadership skills for the practice and management of successfully administering and advocating for an academic pathology department to meet the demands of the three departmental missions within an academic health system: practice, medical education, and research.
- EDUCATIONAL STRATEGIES: Faculty development and enhancing medical education content are valued and prioritized to develop both the pedagogy and knowledge for the identified gaps in the continuum from undergraduate, graduate, and continuing medical education for both domestic and international trainees and practicing pathologists.
- INNOVATIVE DISCOVERIES: Strategies to sustain a department include addressing (a) the laboratory workforce with evolving technology and novel research programs and collaborations, (b) the training and development of trainees, faculty, and staff in today’s employment market, and (c) how to adapt to new regulatory and financial environments for academic laboratories.
ACCREDITATION STATEMENT FOR CONTINUING MEDICAL EDUCATION (CME): This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Society of Cytopathology (ASC) and the Association for Academic Pathology (AAPath). The ASC is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT: The ASC/AAPath designates this other/blended (live and recorded) educational activity for a maximum of 39.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
RELEASE DATE: July 22, 2026 EXPIRATION DATE: October 31, 2026
DISCLOSURES: The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the ASC/AAPath and to learners any financial relationships that have occurred within the last 24 months with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ASC/AAPath has reviewed the disclosures as listed below and mitigated all relevant financial relationships. All other planning committee members and speakers listed below have reported no relevant financial relationships. The AAPath staff associated with the development of content for this activity reported no relevant financial relationships.
SUMMARY OF CONFLICTS OF INTEREST DISCLOSURES
| Name |
Name of Ineligible Company |
Nature of Relevant Relationship |
Mechanism implemented to mitigate relevant financial relationships appropriate to role in the activity. |
| Jiaoti Huang, MD, PhD |
Artera |
Stock options, Consultant |
Education only addresses non-clinical topic |
| Kingmed Diagnostics |
Consultant fee, Consultant |
| MoreHealth |
Stock options, Consultant |
| Jenny Libien, MD, PhD |
Merck & Co, Inc |
Stockholder, Investor |
Education only addresses non-clinical topic |
| Texas Instruments |
Stockholder, Investor |
| McKesson Corporation |
Stockholder, Investor |
| Kimberly Sanford, MD |
Nova Biomedical |
Honorarium, Speaker |
Education only addresses non-clinical topic |
| Mark Tykocinski, MD |
KAHR Medical (Cancer ImmunoRx)
|
Founding Science; Chair, Scientific Advisory Board; Equity Position as Founder |
Education only addresses non-clinical topic |
The following individuals have reported no relevant financial relationships (as of June 13, 2026):
|
Melissa Allen, MS
Leslie Antinarella
Cade Arries, MD
David Bailey, MD
Julie Beckerdite, MBA
Michael J. Borowitz, MD, PhD
Philip Boyer, MD, PhD
Daniel Brat, MD, PhD
Kevin Carnevale, MD
Meagan Chambers, MD, MS, MSc
Joanna Chan, MD
Christopher Cheney, MS
Deborah Chute, MD
Lee Cooper, PhD
James Crawford, MD, PhD
Shanker Deonandan, MBA, MS
Andrea Deyrup, MD, PhD
Barbara Ducatman, MD
Marie Durgin-Hanson
Renee Edwards, MD, MBA
Melissa Erb
Guang Fan, MD, PhD
Carlos Garcia, MBA
Sara Gross, BSW, C-TAGME
|
Carmen Gomez-Fernandez, MD
Jerad Gardner, MD
Kelly Hain
Margaret Harrison, MHA
Cynthia Hayne, MD, PhD
Tiffany Hebert, MD
Samar Hegazy, MD, PhD
Katie Horton
Eric Huang, MD, PhD
Peng Ji, PhD
Merce Jorda, MD, PhD, MBA
Samer Khader, MD
Mark Kilgore, MD
Madhurima Koka, MD, PhD
Debra G B Leonard, MD, PhD
Madelyn Lew, MD, MHPE
Joann Li, MPH
Evelyn Lockhart, MD, MScBMC
Marta Margeta, MD, PhD
Heidi Martinez
Maria Martinez-Lage, MD
Susan McCarthy, BA
Erin McLaughlin, MA
Kelly McNeill, MSEd
|
Mikala Moreau, BS, C-TAGME
Kenechukwu Ojukwu, MD, MPP, MS
William A. Muller, MD, PhD
Lynette Parker, MD
Richard Peng
Andrea Price Carter, MPA
Gary Procop, MD, MS, MEd
Barbara Ritschel, MD
Cindy Riyad, PhD
Cory Roberts, MD, MBA
Suria Sadat, MPA
Vikki Scott, BS, C-TAGME
Brad Seaton, MBA
Beth Smith, C-TAGME
Kristen Smith
Amy Spiczka, DHSc, MS,
Melissa Stedman,
Melissa Sullivan,
Kelley Suskie, MHSA
Georg von Bormann, MSc, MBA
Kai Wang, MBA
Christina M. Wojewoda, MD
Deng Yanxiang, PhD
|
Questions?
Contact us: [email protected] or 302-660-4940
|
